Gyre Therapeutics Inc (GYRE)

R&D Expenses

$33.05M

TTM · Period ending: · USD

GYRE logo

GYRE R&D Expenses

Latest reported$33.05M
GYRE R&D Expenses ($8.15M → $33.05M)
High-resolution chart · PNG

GYRE r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
13,698,000
12,024,000
13,780,000
16,686,000
64,574,000
52,975,000
43,859,000
21,474,000
12,847,000
11,555,000
5,958,000
5,267,000
38,840,000
49,087,000
95,215,000
64,546,000
40,179,000
40,981,000
34,619,494
21,787,873
24,251,463
22,770,881
18,179,000
16,244,000
8,152,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.